The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
September 19th 2024
EDG-7500 was well-tolerated in healthy patients in Phase 1 while achieving gradient relief without LVEF reductions in the Phase 2 CIRRUS-HCM trial.
September 12th 2024
September 10th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
CHEST Releases New Guidance for Perioperative Management of Antithrombotic Therapy
August 12th 2022On August 11, the American College of Chest Physicians (CHEST) released 44 new evidence-based recommendations in their new guidelines for perioperative management of antithrombotic therapy, which were published with the intention of replacing the 2012 guidelines on the subject.
In Obstructive Sleep Apnea, Soft-Tissue Surgery Can Improve Cardiometabolic Health Profile
August 11th 2022A systematic review and meta-analysis provide an overview of the potential improvements in cardiometabolic health profile, including changes in HDL-C, LDL-C, and triglycerides, observed after patients with obstructive sleep apnea have undergone soft-tissue surgery.
Salt Substitutes Linked to Lower Blood Pressure, Reduced Event and Mortality Risk
August 10th 2022A systematic review and meta-analysis from SSaSS investigators provide further insight into the reductions in blood pressure observed with use of a salt substitute, as well as the impact of use on overall risk of mortality and mortality from cardiovascular-specific causes.
Artificial Intelligence Tools Could Use ECGs to Predict Type 2, Prediabetes
August 10th 2022Called the DiaBeats algorithm, new research suggests leveraging the machine learning-based algorithm, combined with ECG recordings, could help predict increased risk of developing prediabetes and type 2 diabetes.
GnRH Agonists for Prostate Cancer Could Increase CVD Risk in Type 2 Diabetes
August 9th 2022New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.
Cardiology Case Report: Early Morning Chest Pain
August 6th 2022Our latest case report from Brady Pregerson, MD, features a patient in their mid-70s presenting to the hospital with chest pain since 2 AM that became constant at 5 AM and made him vomit. Check out the EKG and determine the correct diagnosis!
Patisiran Meets Primary Endpoint in APOLLO-B Trial
August 3rd 2022Already approved by the FDA for the treatment of the polyneuropathy of hATTR amyloidosis, the August 3rd announcement of APOLLO-B results from Alnylam Pharmaceuticals suggests patisiran (ONPATTRO) could be a safe and efficacious treatment option for patients with ATTR amyloidosis with cardiomyopathy.
Traditional Cardiovascular Disease Risk Scores Offer Similar Value as Polygenic Risk Score
August 1st 2022An analysis of data from a pair of major studies provides insight into the use of a traditional 30-year risk score against a polygenic risk score for predicting coronary heart disease based on risk score across multiple age groups
Androgen Deprivation Therapy Could Increase Cardiovascular Risk for Prostate Cancer Patients
July 27th 2022Undergoing androgen deprivation therapy as part of treatment for prostate cancer was linked to a more than 2-fold increase in risk of cardiovascular disease-related death, according to a new study.
Cardiology Case Report: Chest Pain After CABG
July 25th 2022Our latest case report from Brady Pregerson, MD, features a man in his mid-70s with a history of AFib on warfarin and a recent CABG brought in by ambulance with worsening chest pain and shortness of breath. Can you determine the correct diagnosis?
Real-World Data Links Rosuvastatin to Nephrotoxicity
July 22nd 2022An analysis of real-world EHR data from more than 900,000 statin users suggests use of rosuvastatin was associated with an 8% greater risk of hematuria, a 17% greater risk of proteinuria, and a 15% higher risk of developing kidney failure requiring replacement therapy such as dialysis or transplantation compared to atorvastatin use.